Quick Links PEG-INTRON® REBETOL® INTRONA® Hepatitis Risk Assessment Resources FAQs What Is Hepatitis? How Is Hepatitis Spread? Treatment for Hepatitis Living with Hepatitis	INTRON® A Important Safety Information WARNING Alpha interferons, including INTRON® A, cause or aggravate fatal or life-threatening neuropsychiatric, autoimmune, ischemic, and infectious disorders. Patients should be monitored closely with periodic clinical and laboratory evaluations. Patients with persistently severe or worsening signs or symptoms of these conditions should be withdrawn from therapy. In many but not all cases these disorders resolve after stopping INTRON A therapy. All patients receiving INTRON A therapy experienced mild-to-moderate side effects. Some patients experienced more severe side effects, including neutropenia, fatigue, myalgia, headache, fever, chills, and increased SGOT. Other frequently occurring side effects were nausea, vomiting, depression, alopecia, diarrhea, and thrombocytopenia. DEPRESSION AND SUICIDAL BEHAVIOR, INCLUDING SUICIDAL IDEATION, SUICIDAL ATTEMPTS, AND COMPLETED SUICIDES, HAVE BEEN REPORTED IN ASSOCIATION WITH TREATMENT WITH ALFA INTERFERONS, INCLUDING INTRON A THERAPY. See also: INTRON® A Prescribing Information Side Effects of INTRON® A Important Safety Information About REBETRON® Combination Therapy Return to Top
	Terms and ConditionsPrivacy Policy Copyright © 2002, Schering Corporation, Kenilworth, NJ 07033. All rights reserved.